RN7SL362P

Across TCGA pan-cancer cohorts, RN7SL362P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL362P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL362P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL362P is over-expressed in tumor.

LUAD, HNSC, and KIRC are the cancer types where RN7SL362P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL362P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.230	.030	1	view →
HNSC	Male	All	+0.062	.040	1	view →
KIRC	Male	II,III,IV	+0.030	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL362P–LUAD

Open the LUAD breakdown →